Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Anti-SARS2 RBD Antibody (S2H97)
Anti-SARS2 RBD Antibody (S2H97) from MyBioSource.com
Be the first to write a review!
Supplier Page
Supplier Page from
MyBioSource.com for
Anti-SARS2 RBD Antibody (S2H97)
Get Pricing
MyBioSource.com's
Anti-SARS2 RBD Antibody (S2H97)
is a Human monoclonal antibody. It reacts with 2019-nCoV, Corona Virus, Coronavirus, COVID-19, SARS-CoV-2, and Virus.
Product Specs
Company Info
Reviews
Product Specs
Item
Anti-SARS2 RBD Antibody (S2H97)
Company
MyBioSource.com
Price
$375.00
Supplier Page
View Company Product Page
Catalog Number
MBS1564030
Clonality
Monoclonal
Isotype
IgG1 kappa
Reactivity
SARS-CoV-2(2019-nCoV)
Format
Liquid. PBS buffer, pH7.4
Clone
S2H97
Host
Human
Quantity
0.1 mg
Target
S2H97
Conjugate/Tag
Unconjugated
Concentration
1mg/ml
Purity
>95%; Protein A or G purified from cell culture supernatant
Add to Compare List
MyBioSource.com
P.O. Box 153308
San Diego
,
California
United States
Phone
: 1-888-627-0165 (toll free) or 1-858-633-0165
Fax: 1-858-633-0166
Email: sales@mybiosource.com
Company Profile
Website:
http://www.MyBioSource.com
Reviews
Be the First to Write a Review!
Anti-SARS2 RBD Antibody (S2H97) from MyBioSource.com
Supplier Page
View Company Product Page
$375.00
Product Specs
Company Info
Reviews
Back To Top